Dr. Johnson on Promise of Combination Therapy in Melanoma
4 Ansichten
• 07/30/23
0
0
Einbetten
administrator
Abonnenten
Douglas B. Johnson, MD, assistant professor of medicine, Vanderbilt University Medical Center, clinical director, Melanoma Research Program, Vanderbilt-Ingram Cancer Center, discusses the promise of combination therapy in patients with melanoma.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare